Literature DB >> 14499463

Calcium signaling dysfunction in schizophrenia: a unifying approach.

Michael S Lidow1.   

Abstract

The present paper demonstrates a remarkable pervasiveness of underlying Ca(2+) signaling motifs among the available biochemical findings in schizophrenic patients and among the major molecular hypotheses of this disease. In addition, the paper reviews the findings suggesting that Ca(2+) is capable of inducing structural and cognitive deficits seen in schizophrenia. The evidence of the ability of antipsychotic drugs to affect Ca(2+) signaling is also presented. Based on these data, it is proposed that altered Ca(2+) signaling may constitute the central unifying molecular pathology in schizophrenia. According to this hypothesis schizophrenia can result from alterations in multiple proteins and other molecules as long as these alterations lead to abnormalities in certain key aspects of intracellular Ca(2+) signaling cascades.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499463     DOI: 10.1016/s0165-0173(03)00203-0

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  56 in total

1.  Exploring schizophrenia drug-gene interactions through molecular network and pathway modeling.

Authors:  Daniel K Putnam; Jingchun Sun; Zhongming Zhao
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

2.  D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.

Authors:  Asim J Rashid; Christopher H So; Michael M C Kong; Teresa Furtak; Mufida El-Ghundi; Regina Cheng; Brian F O'Dowd; Susan R George
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-28       Impact factor: 11.205

Review 3.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

Review 4.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

Review 5.  Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.

Authors:  Melissa L Perreault; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

6.  A molecule-based genetic association approach implicates a range of voltage-gated calcium channels associated with schizophrenia.

Authors:  Wen Li; Chun Chieh Fan; Tuomo Mäki-Marttunen; Wesley K Thompson; Andrew J Schork; Francesco Bettella; Srdjan Djurovic; Anders M Dale; Ole A Andreassen; Yunpeng Wang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-04-28       Impact factor: 3.568

7.  Role of cholinergic system and calcium synchronization in schizophrenia.

Authors:  Atmaram Yarlagadda; Anita H Clayton
Journal:  Psychiatry (Edgmont)       Date:  2009-04

8.  Energization by multiple substrates and calcium challenge reveal dysfunctions in brain mitochondria in a model related to acute psychosis.

Authors:  Jamila Monteiro; Gabriela Assis-de-Lemos; Eduardo de-Souza-Ferreira; Adriana M Marques; Gilda A Neves; Mariana S Silveira; Antonio Galina
Journal:  J Bioenerg Biomembr       Date:  2019-12-18       Impact factor: 2.945

9.  Golli Myelin Basic Proteins Modulate Voltage-Operated Ca(++) Influx and Development in Cortical and Hippocampal Neurons.

Authors:  V T Cheli; D A Santiago González; V Spreuer; V Handley; A T Campagnoni; P M Paez
Journal:  Mol Neurobiol       Date:  2015-10-26       Impact factor: 5.590

10.  Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth.

Authors:  Ahmed Hasbi; Theresa Fan; Mohammad Alijaniaram; Tuan Nguyen; Melissa L Perreault; Brian F O'Dowd; Susan R George
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.